1. European Medicines Agency. Committee for Proprietary Medicinal Products (CPMP). Position paper on terminology in pharmacogenetics. EMEA/CPMP/3070/01. London, 21 November 2002 [consultado 28/2/2010]. Disponible en: http://www.emea.europa.eu/pdfs/human/press/pp/307001en.pdf.
2. European Medicines Agency. ICH Topic E15. Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories. EMEA/CHMP/ICH/437986/2006. London, November 2007 [consultado 28/2/2010]. Disponible en: http://www.emea.europa.eu/pdfs/human/ich/43798606en.pdf.
3. Pharmacogenetics in drug discovery and development: A translational perspective;Roses;Nat Rev Drug Discov,2008
4. Farmacogenómica y medicina personalizada en la sanidad española. Estudio de prospectiva Ed: Fundación OPTI/Genoma España; Ministerio de Industria Turismo y Comercio. 2009 [consultado 28/2/2010]. Disponible en: http://www.opti.org/publicaciones/pdf/texto123.pdf.
5. FDA. Guidance for Industry and FDA Staff. Pharmacogenetic tests and genetic tests for heritable markers. Document issued on June 19, 2007 [consultado 28/2/2010]. Disponible en: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071075.pdf.